Author

J. M. Cable

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

M. A. Luftig· 2 shared E. N. Bonglack· 1 shared H. R. Christofk· 1 shared J. Ch'ng· 1 shared J. E. Messinger· 1 shared M. Parnell· 1 shared N. M. Reinoso-Vizcaino· 1 shared R. E. White· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. A. Luftig

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote naïve B cell transformation

J. M. Cable, R. E. White, N. M. Reinoso-Vizcaino, M. A. Luftig

This study identifies EBNA-LP's role in promoting naive B cell transformation by interacting with YY1 through conserved leucine-rich motifs.

bioRxiv · Jan 7, 2024Microbiology

Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas

E. N. Bonglack, J. E. Messinger, J. M. Cable, M. Parnell, J. Ch'ng, H. R. Christofk, M. A. Luftig

This study shows that inhibiting MCT1 and MCT4 in EBV-driven lymphomas disrupts metabolism, leading to growth arrest and sensitization to metformin, revealing a potential therapeutic strategy.

bioRxiv · Dec 4, 2020Cancer Biology